We are live on ! Find out more
ATRC icon

AtriCure

107 hedge funds and large institutions have $683M invested in AtriCure in 2017 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 38 increasing their positions, 35 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 6

22% more capital invested

Capital invested by funds: $560M → $683M (+$123M)

8% more funds holding

Funds holding: 99107 (+8)

9% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 35

0% more funds holding in top 10

Funds holding in top 10: 55 (0)

4.82% less ownership

Funds ownership: 87.81%82.99% (-4.8%)

25% less call options, than puts

Call options by funds: $313K | Put options by funds: $420K

Holders
107
Holders Change
+8
Holders Change %
+8.08%
% of All Funds
2.67%
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.12%
New
14
Increased
38
Reduced
35
Closed
6
Calls
$313K
Puts
$420K
Net Calls
-$107K
Net Calls Change
+$511K

ATRC Hedge Fund Activity: Q2 2017 in Review

107 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q2 2017, worth a combined $683M — up 22% from $560M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new ATRC positions and 6 closed out — a net gain of 8 holders — while 38 added to existing stakes and 35 trimmed.

The largest buyer was Neuberger Berman Group, adding an estimated $5.48M. The largest seller was Wellington Management Group, cutting an estimated $27.2M.

  • 107 institutional investors held AtriCure (ATRC) as of Q2 2017, up from 99 in Q1 2017.
  • Funds reported $683M of AtriCure stock for Q2 2017, up 22% quarter-over-quarter.
  • 14 funds opened new AtriCure positions in Q2 2017 and 6 closed out, a net change of +8 holders.
  • The largest AtriCure buyer in Q2 2017 was Neuberger Berman Group, an estimated $5.48M added.
  • The largest AtriCure seller in Q2 2017 was Wellington Management Group, an estimated $27.2M sold.

Based on aggregated 13F filings for Q2 2017.